NEW YORK, Aug. 12, 2019 /PRNewswire/ -- Integrated Care Physicians, Inc. ("ICP" or the "Company"), a provider of Emergency Medicine and Acute Care management services and a BelHealth Investment Partners ("BelHealth") portfolio company, announced that Dr. Terry Meadows has joined the Company as Executive Chairman and Board Member.

BETHESDA, Md., Aug. 12, 2019 /PRNewswire/ -- The 2019 Community Health Institute (CHI) and EXPO, hosted by the National Association of Community Health Centers (

MARLBOROUGH, Mass., Aug. 12, 2019 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (sd-rxRNA®) therapeutic platform, today reported its financial results for the second quarter ended June 30,

SOUTH SAN FRANCISCO, Calif., Aug. 12, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA)  today announced plans to offer, subject to market and other conditions, $200 million of its common stock in an underwritten public offering. The company expects to grant the underwriters a 30-day option to purcha

GARDNER, Mass., Aug.12, 2019 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the "Company") today announced that it has scheduled a conference call to discuss preliminary fourth quarter and fiscal 2019 revenue as well as its recent acquisition of Ross Optical Industries on Thursday, August 15, 2019 at 5:00pm ET.

WASHINGTON, Aug. 12, 2019 /PRNewswire/ -- Today, the Department of Homeland Security (DHS) finalized a new rule that will deter use of vital services for some immigrant populations. Fourteen patient groups released the following statement in response to this rule being finalized:"Our organizations represent millions of patients and consumers, including many

LAKE FOREST, Calif., Aug. 12, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq:INMD) ("InMode") announced today the closing of its initial public offering of 5,000,000 ordinary shares at an initial public offering price of $14.00 per ordinary share. The aggregate gross proceeds, before deducting underwriting discounts and commissions and other

SAN JOSE, Calif., Aug. 12, 2019 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of targeted immunotherapies using fully human monoclonal antibodies (mAbs) to treat life-threatening bacterial infections, today reported financial and corporate results for the second quarter ended&

SAN DIEGO, Aug. 12, 2019 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to i

AUSTIN, Texas, Aug. 12, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the second quarter ended June 30, 2019. Volition management will host a conference call tomorrow, August 13, at 8:30 a.m.